We create value.
aXichem is an innovative biotechnology company specialising in development of natural analogue ingredients.
We create value.
Aktiedata
AXICHEM A
(AXIC A)
47.6
SEK
-0.4 / -0.83%
High
48.4
Low
47.6
Volume
1078
Turnover
51384
January 25, 2021 09:56:53
Financial Calendar
Year-end report 2020 - 24 February 2021
Interim report 1/2021 - 13 May 2021
Interim report 2/2021 - 18 August 2021
Interim report 3/2021 - 11 November 2021
Year-end report 2021 - 17 February 2022
Company description
We draw from the genius of nature and respect nature in return.
aXichem Bolagsbeskrivning 131121
PDF 1.28 MB
Meetings Archive
Financial Advisor and Certified Advisor
Redeye AB
Box 7141
103 87 Stockholm
08-545 013 30
www.redeye.se
We create value.
Investor Structure
Largest owners as of 31 March 2019 aXichem’s ten largest owners according to the shareholders’ register kept by Euroclear
| Name | No. of shares | Participating interest (%) |
| Manakin Ltd | 1 915 391 | 12,02 |
| LMK -bolagen | 1 686 697 | 10,59 |
| Försäkringsaktiebolaget Avanza Pension | 859 499 | 5,40 |
| Danica Pension | 806 784 | 5,06 |
| Nordnet Pensionsförsäkring AB | 619 590 | 3,89 |
| Redoterm AB | 365 501 | 2,29 |
| IBKR Financial Service AG | 336 343 | 2,11 |
| SEB Life International Ass Co Ltd | 302 223 | 1,90 |
| Hans Sköld | 289 077 | 1,81 |
| Per Vasilis | 281 047 | 1,76 |
Investor enquiries
Subscribe to information
from Axichem via First
North.